Ardelyx Wins Three PM360 Trailblazer Awards in 2026

  • Ardelyx won three PM360 Trailblazer Awards on September 29, 2026, including CEO of the Year for Mike Raab.
  • The company's podcast, Gut Matters, won Gold in the Podcast Initiative category.
  • Ardelyx's IBSRELA Marketing Team received the Silver Marketing Team of the Year award.
  • Raab has led Ardelyx since 2009, guiding it from early-stage biotech to a commercial, multi-product biopharmaceutical company.

Ardelyx's recognition at the PM360 Trailblazer Awards underscores its shift from a development-stage biotech to a commercial player with a growing product portfolio. The awards highlight the company's strategic focus on patient advocacy and innovative marketing, aligning with broader industry trends toward patient-centric engagement and digital health education. With two approved products and a developing pipeline, Ardelyx is positioning itself as a key player in gastrointestinal therapeutics.

Leadership Impact
How Mike Raab's continued leadership will influence Ardelyx's transition to a multi-product biopharmaceutical company.
Marketing Effectiveness
Whether the IBSRELA Marketing Team's patient-focused approach can sustain commercial growth.
Content Strategy
The pace at which Ardelyx's educational initiatives, like Gut Matters, drive patient and advocacy engagement.